多骨性纤维结构不良的68Ga-PSMA-HBED-CC PET/CT表现
一例43岁男性McCune-Albright综合征伴纤维结构不良患者按机构方案行18F-氟化钠骨扫描和68Ga-PSMA-HBED-CC PET/CT。骨扫描显示中轴骨和附肢骨广泛受累,确诊多骨性纤维结构不良;68Ga-PSMA PET/CT在相应纤维结构不良病灶中显示示踪剂摄取增高。作者指出PSMA在纤维结构不良病灶中的摄取罕见报道,但随PSMA PET/CT应用增多,需认识此假阳性表现以避免误判。
要点
- 纤维结构不良病灶可出现68Ga-PSMA摄取增高,属假阳性表现。
- 18F-氟化钠骨扫描可显示多骨性纤维结构不良的广泛骨骼受累。
- PSMA PET/CT判读时应警惕纤维结构不良所致假阳性,避免误诊。
核心结论
- 纤维结构不良病灶在68Ga-PSMA PET/CT上可表现为示踪剂摄取增高,应被视为假阳性表现以避免误判。
研究设计与样本
- 个案报道:一例43岁男性McCune-Albright综合征伴纤维结构不良患者按机构方案行18F-氟化钠骨扫描和68Ga-PSMA-HBED-CC PET/CT。
主要发现
- 18F-骨扫描显示中轴骨和附肢骨广泛受累,证实多骨性纤维结构不良。
- 68Ga-PSMA PET/CT显示纤维结构不良相应病灶中示踪剂摄取增高。
临床怎么用
- PSMA PET/CT判读时需认识纤维结构不良病灶可摄取PSMA,避免将其误判为肿瘤性病变。
局限性
- PSMA在纤维结构不良病灶中的摄取罕见报道,文献证据仅限于个案报道。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 43-year-old man diagnosed with fibrous dysplasia with McCune-Albright syndrome was subjected to 18F-fluoride bone scan and 68Ga-PSMA-HBED-CC PET/CT as per the institution protocol. 18F-bone scan revealed extensive involvement of axial and appendicular skeleton confirming polyostotic fibrous dysplasia. 68Ga-PSMA PET/CT showed increased tracer uptake in corresponding lesions of fibrous dysplasia. PSMA uptake in fibrous dysplasia lesions has been rarely described with literature evidence being limited to anecdotal case reports. Nevertheless, due to increasing use of PSMA PET/CT, one should be aware of this false-positive finding to avoid misinterpretation of the scans.
引用
- Malhotra G, Aute PP, Awasare S, et al. 68Ga-PSMA-HBED-CC PET/CT Findings in a Patient of Polyostotic Fibrous Dysplasia. Clin Nucl Med. 2021. PMID: 33417342. doi:10.1097/RLU.0000000000003492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。